NKGen Biotech

(OTC) NKGN

Current Price$0.06

Market Cap$7.84M

Since IPO (2021)-99%

5 YearN/A

1 Year-80%

1 Month+0%

NKGen Biotech Financials at a Glance

Market Cap

$7.84M

Revenue (TTM)

$652.00K

Net Income (TTM)

-$23.55M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.06

Volume

1,164

Open

$0.06

Price

$0.06

Volume

1,164

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.00 - $0.33

Estimated Earnings Date

Mar 2, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.06

Volume

1,164

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.00 - $0.33

Estimated Earnings Date

Mar 2, 2026

NKGN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NKGen Biotech

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Paul Y. Song, MD, PhD

Website

www.nkgenbiotech.com

Headquarters

Santa Ana, CA 92705, US

NKGN Financials

Key Financial Metrics (TTM)

Gross Margin

50.00%

Operating Margin

-1497.85%

Net Income Margin

-2157.06%

Return on Equity

55.88%

Return on Capital

N/A

Return on Assets

-88.78%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.84M

Shares Outstanding

130.60M

Volume

1.16K

Avg. Volume

3.00K

Financials (TTM)

Gross Profit

$326.00K

Operating Income

-$24.01M

EBITDA

$21.54M

Operating Cash Flow

-$19.65M

Capital Expenditure

-$52.00K

Free Cash Flow

-$19.70M

Cash & ST Invst.

$6.00K

Total Debt

$38.19M

NKGen Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$7.84M

N/A

Market Cap/Employee

$301.39K

N/A

Employees

N/A

Net Income

$15.35M

+385.2%

EBITDA

$16.24M

+507.3%

Quarterly Fundamentals

Name

Q1 2025YOY CHG

Total Cash

$6.00K

-82.4%

Total Debt

$38.19M

+71.9%

Accounts Receivable

$23.00K

-11.5%

Inventory

$0.00

N/A

Long Term Debt

$11.28M

+7.5%

Short Term Debt

$26.91M

+129.6%

Return on Assets

-88.78%

N/A

Return on Invested Capital

34.82%

N/A

Free Cash Flow

-$2.85M

+29.3%

Operating Cash Flow

-$2.80M

+30.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MLECMoolec Science S.A.

MLECMoolec Science S.A.$7.97+3.02%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$1.18-7.81%

NCELNewcelX Ltd.

NCELNewcelX Ltd.$3.85+0.00%

ATXIAvenue Therapeutics, Inc.

ATXIAvenue Therapeutics, Inc.$0.31+8.93%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.34-2.90%

WINTWindtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.$0.02+100.00%

VRAXVirax Biolabs Group Limited

VRAXVirax Biolabs Group Limited$3.13+14.23%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

INTCIntel

INTCIntel$120.35-0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.05%

Questions About NKGN

What is the current price of NKGen Biotech?

NKGen Biotech is trading at $0.06 per share.

What is the 52-week range for NKGen Biotech?

Over the past 52 weeks, NKGen Biotech has traded between $0.00 and $0.33.

How much debt does NKGen Biotech have?

As of the most recent reporting period, NKGen Biotech reported total debt of $38.19M.

How much cash does NKGen Biotech have on hand?

NKGen Biotech reported $29.00K in cash and cash equivalents in its most recent financial results.

What is NKGen Biotech’s dividend yield?

NKGen Biotech does not currently have a dividend yield.

NKGen Biotech

NKGen Biotech Financials at a Glance

NKGN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NKGen Biotech

NKGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NKGen Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NKGN

What is the current price of NKGen Biotech?

What is the 52-week range for NKGen Biotech?

How much debt does NKGen Biotech have?

How much cash does NKGen Biotech have on hand?

What is NKGen Biotech’s dividend yield?

Premium Investing Services